Adherence to Cancer Prevention Guidelines and Endometrial Cancer Risk: Evidence from a Systematic Review and Dose-Response Meta-analysis of Prospective Studies
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The evidence of adherence to cancer prevention guidelines and endometrial cancer (EC) risk has been limited and controversial. This study summarizes and quantifies the relationship between adherence to cancer prevention guidelines and EC risk. Materials and Methods The online databases PubMed, Web of Science, and EMBASE were searched for relevant publications up to June 2, 2020. This study had been registered at PROSPERO. The registration number is CRD42020149966. Study quality evaluation was performed based on the Newcastle-Ottawa Scale. The I2 statistic was used to estimate heterogeneity among studies. Egger’s and Begg’s tests assessed potential publication bias. Summary hazard ratios (HRs) and 95% confi dence intervals (CIs) for the relationship between adherence to cancer prevention guidelines score was assigned to participants by summarizing individual scores for each lifestyle-related factor. The scores ranged from least healthy (0) to most healthy (20) and the EC risk was calculated using a random-effects model. Results Five prospective studies (four cohort studies and one case‑cohort study) consisted of 4,470 EC cases, where 597,047 participants were included. Four studies had a low bias risk and one study had a high bias risk. Summary EC HR for the highest vs. lowest score of adherence to cancer prevention guidelines was 0.54 (95% CI, 0.40 to 0.73) and had a high heterogeneity (I2=86.1%). For the dose-response analysis, an increment of 1 significantly reduced the risk of EC by 6%. No signifi cant publication bias was detected. Conclusion This study suggested that adherence to cancer prevention guidelines was negatively related to EC risk.
Abstract
Purpose The evidence of adherence to cancer prevention guidelines and endometrial cancer (EC) risk has been limited and controversial. This study summarizes and quantifies the relationship between adherence to cancer prevention guidelines and EC risk. Materials and Methods The online databases PubMed, Web of Science, and EMBASE were searched for relevant publications up to June 2, 2020. This study had been registered at PROSPERO. The registration number is CRD42020149966. Study quality evaluation was performed based on the Newcastle-Ottawa Scale. The I2 statistic was used to estimate heterogeneity among studies. Egger’s and Begg’s tests assessed potential publication bias. Summary hazard ratios (HRs) and 95% confi dence intervals (CIs) for the relationship between adherence to cancer prevention guidelines score was assigned to participants by summarizing individual scores for each lifestyle-related factor. The scores ranged from least healthy (0) to most healthy (20) and the EC risk was calculated using a random-effects model. Results Five prospective studies (four cohort studies and one case‑cohort study) consisted of 4,470 EC cases, where 597,047 participants were included. Four studies had a low bias risk and one study had a high bias risk. Summary EC HR for the highest vs. lowest score of adherence to cancer prevention guidelines was 0.54 (95% CI, 0.40 to 0.73) and had a high heterogeneity (I2=86.1%). For the dose-response analysis, an increment of 1 significantly reduced the risk of EC by 6%. No signifi cant publication bias was detected. Conclusion This study suggested that adherence to cancer prevention guidelines was negatively related to EC risk.
참고문헌 (30)
- Ferlay J, "Estimates of cancer incidence and mortality in Europe in 2008", Eur J Cancer, 46, pp.765~781 (2010)
- Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Sorosky JI, "Endometrial cancer", Obstet Gynecol, 120, pp.383~397 (2012)
- Constantine GD, "Increased incidence of endometrial cancer following the Women’s Health Initiative : an assessment of risk factors", J Womens Health(Larchmt), 28, pp.237~243 (2019)
- Avgerinos KI, "Obesity and cancer risk : emerging biological mechanisms and perspectives", Metabolism, 92, pp.121~135 (2019)
- Linkov F, "Focus on gynecologic malignancies. Energy balance and cancer, Vol. 13", pp.137~165 (2018), Springer
- Gierach GL, "Physical activity, sedentary behavior, and endometrial cancer risk in the NIH-AARP Diet and Health Study", Int J Cancer, 124, pp.2139~2147 (2009)
- Kawachi A, "Association of BMI and height with the risk of endometrial cancer, overall and by histological subtype : a population-based prospective cohort study in Japan", Eur J Cancer Prev, 28, pp.196~202 (2019)
- Dunneram Y, "Diet, menopause and the risk of ovarian, endometrial and breast cancer", Proc Nutr Soc, 78, pp.438~448 (2019)
- Pronk NP, "Meeting recommendations for multiple healthy lifestyle factors : prevalence, clustering, and predictors among adolescent, adult, and senior health plan members", Am J Prev Med, 27, pp.25~33 (2004)
- Arthur R, "Associations of a healthy lifestyle index with the risks of endometrial and ovarian cancer among women in the Women’s Health Initiative Study", Am J Epidemiol, 188, pp.261~273 (2019)
- Arthur R, "A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women", Cancer Causes Control, 29, pp.485~493 (2018)
- Dartois L, "Association between five lifestyle habits and cancer risk : results from the E3N cohort", Cancer Prev Res(Phila), 7, pp.516~525 (2014)
- Thomson CA, "Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women’s health initiative", Cancer Prev Res(Phila), 7, pp.42~53 (2014)
- Kabat GC, "Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality : a prospective cohort study", Am J Clin Nutr, 101, pp.558~569 (2015)
- Romaguera D, "Is concordance with World Cancer Research Fund", American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study, 2012, pp.96, 150~163
- Wells GA, "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses" (2013), University of Ottawa;
- Gong TT, "Observational studies on the association between post-diagnostic metformin use and survival in ovarian cancer : a systematic review and meta-analysis", Front Oncol, 9, pp.458~ (2019)
- DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)
- Greenland S, "Methods for trend estimation from summarized dose-response data, with applications to meta-analysis", Am J Epidemiol, 135, pp.1301~1309 (1992)
- Chang SC, "Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study", Cancer Epidemiol Biomarkers Prev, 16, pp.723~730 (2007)
- Lee SC, "The oncogenic potential of endometrial polyps : a systematic review and meta-analysis", Obstet Gynecol, 116, pp.1197~1205 (2010)
- Kushi LH, "American Cancer Society guidelines on nutrition and physical activity for cancer prevention : reducing the risk of cancer with healthy food choices and physical activity", CA Cancer J Clin, 62, pp.30~67 (2012)
- Kushi LH, "American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention : reducing the risk of cancer with healthy food choices and physical activity", CA Cancer J Clin, 56, pp.254~281 (2006)
- Giovannucci E, "Insulin, insulin-like growth factors and colon cancer : a review of the evidence", J Nutr, 131, pp.3109~ (2001)
- Chan Lee, "Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical andEndometrial Cancer", Cancer Research and Treatment, 35(4), pp.314~322 (2003), 대한암학회
- Renehan AG, "Bodymass index and incidence of cancer : a systematic review and meta-analysis of prospective observational studies", Lancet, 371, pp.569~578 (2008)
- Gunter MJ, "A prospective evaluation of insulin and insulinlike growth factor-I as risk factors for endometrial cancer", Cancer Epidemiol Biomarkers Prev, 17, pp.921~929 (2008)
- Giovannucci E, "Nutrition, insulin, insulin-like growth factors and cancer", Horm Metab Res, 35, pp.694~704 (2003)